What happened
SK Discovery updated a subsidiary's previously disclosed supply contract with AKSIA Health Care FZC, now worth US$26.1M, about 36.74% of the subsidiary's recent annual revenue, running through Apr 2026.
For context, this single contract equals about 36.74% of the subsidiary's most recent annual revenue.
| Counterparty | AKSIA Health Care FZC |
|---|---|
| Contract value | US$26.1M |
| vs. subsidiary revenue | 36.74% |
| Through | Apr 2026 (from Jan 2022) |
| Filed | 2026-04-03, [Amended] Supply contract signed (subsidiary) |
| Source | DART rcept 20260403801392 → open original filing |
Source: DART. Information only, not investment advice.